No Data
No Data
Clearmind Receives Patent for Molecule That May Reduce Desire for Alcohol
Express News | Clearmind Medicine Inc - Granted U.S. Patent Approval for Binge Behavior Treatment
Clearmind Medicine Shares Are Trading Higher After the Company Announced It Received a Patent Approval From the US Patent and Trademark Office.
Clearmind Medicine Receives New Patent Approval From US Patent And Trademark Office, Marking Significant Advancement In Its Proprietary MEAI-Based Binge Behavior Regulator Program
Trending Stocks Today | SciSparc Surges 43.91% Post-Market
Express News | Clearmind Medicine Shares Are Trading Higher After the Company Announced the Submission of an International Patent in Collaboration With the Yissum Research Development Company
No Data